title: Comparative study of inhaled amiloride and inhaled furosemide in exercise-induced asthma.
abstract: BACKGROUND
  Certain diuretics such as furosemide, when inhaled, have been found to be useful in preventing Exercise-Induced Asthma (EIA).
  
  
  OBJECTIVE
  To assess the possible preventive effect of inhaled amiloride in EIA.
  
  
  METHODS
  A double blind, randomized, cross-over study comparing the effect of inhaled amiloride, inhaled furosemide and placebo in EIA.
  
  
  METHODS
  Sixteen asthmatic patients (8 males and 8 females) with an average age of 21 years (range 9-31) who presented a FEV1 decrease of over 15% in a previous free-running exercise test.
  
  
  METHODS
  Solutions were inhaled with a Hudson nebulizer connected to an oxygen source in different days before exercise testing. A Vitalograph Compact (Ohmeda, England) spirometer was used and FEV1 was obtained at baseline, three minutes after solution inhalation, immediately after exercise and then every 5 min. until 20 minutes post-exercise. The changes in FEV1 percentages (FEV1%) and the mean FEV1 decreases expressed as percentages for each solution were compared.
  
  
  RESULTS
  Inhaled furosemide diminished the fall in the FEV1 at every time after exercise. The maximum decrease in mean FEV1 was at 5 minutes post-exercise and was 11 +/- 7% with furosemide, 24 +/- 14% (p < 0.01) with amiloride and 19 +/- 12% (p < 0.05) with placebo. Amiloride administration resulted in a slight but significative increase in the FEV1 fall (p < 0.01 when compared with placebo).
  
  
  CONCLUSIONS
  Amiloride is not useful to protect EIA whereas Furosemide does it. These differences results may be related to the differents mechanisms of action of the two diuretics.
authors.affiliation: Seccions d'allèrgia i pneumologia, Hospital de la Marina Baixa, La Vila Joiosa (Alacant), Spain.
authors.forename: C H
authors.initials: CH
authors.lastname: Larramendi
authors.forename: E
authors.initials: E
authors.lastname: Chiner
authors.forename: J L
authors.initials: JL
authors.lastname: Calpe
authors.forename: M T
authors.initials: MT
authors.lastname: Puigcerver
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000328:Adult; D000336:Aerosols; D000584:Amiloride / Q000008:administration & dosage / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001250:Asthma, Exercise-Induced / Q000503:physiopathology / Q000517:prevention & control*; D016084:Bronchoconstriction / Q000187:drug effects; D002648:Child; D018592:Cross-Over Studies; D004232:Diuretics / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D005541:Forced Expiratory Volume; D005665:Furosemide / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male
chemical_list: D000336:Aerosols; D018927:Anti-Asthmatic Agents; D004232:Diuretics; D000584:Amiloride; D005665:Furosemide